20 Dec 2022 by admin in UncategorizedComments Kira Pharmaceuticals Announces Clearance to Initiate Phase 2 Evaluation of KP104 in IgA Nephropathy (IgAN) and Complement 3 Glomerulopathy (C3G) in China and Australia
09 Dec 2022 by admin in UncategorizedComments Arcellx And Kite Announce Strategic Collaboration To Co- Develop And Co-Commercialize Late-Stage Clinical CART- DdBCMA In Multiple Myeloma
02 Dec 2022 by admin in UncategorizedComments INNOFORCE OPENS GMP MANUFACTURING FACILITY & CORPORATE HEADQUARTERS IN HANGZHOU, CHINA TO PROVIDE CDMO SERVICES FOR GLOBAL SUPPLY OF RNA, CELL & GENE THERAPIES
